AVEO Pharmaceuticals Cash from Investing Quarterly
AVEO Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -14.94M |
| Sept. 30, 2012 | 51.95M |
| June 30, 2012 | 39.72M |
| March 31, 2012 | 58.51M |
| Dec. 31, 2011 | 16.84M |
| Sept. 30, 2011 | -36.79M |
| June 30, 2011 | -86.10M |
| March 31, 2011 | -38.05M |
| Dec. 31, 2010 | -48.16M |
| Sept. 30, 2010 | 29.08M |
| June 30, 2010 | -52.81M |
| March 31, 2010 | -18.62M |
| Dec. 31, 2009 | 15.40M |
| Sept. 30, 2009 | 11.17M |
| June 30, 2009 | -13.27M |
| March 31, 2009 | -9.888M |
| Sept. 30, 2008 | 30.88M |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
AVEO Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Onyx Pharmaceuticals | |
| Galena Biopharma | |
| Sarepta Therapeutics | -0.423M |
AVEO Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -86.10M | Jun 2011 |
| Maximum | 58.51M | Mar 2012 |
| Average | -3.827M |
AVEO News
Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
Street Insider May 17
Street Insider May 17